PROLOR Biotech, Inc.
7 Golda Meir Street
Weizmann Science Park
Nes-Ziona,
74140
Israel - Map
Phone: 866 644 7811
Fax: 972 8 930 0091
Website: http://www.prolor-biotech.com
PROLOR Biotech, Inc., a development stage biopharmaceutical company, engages in the development of proprietary versions of already-approved therapeutic proteins. Its technology, Carboxyl Terminal Peptide (CTP) is used to develop new and proprietary versions of existing therapeutic proteins that have longer life spans than therapeutic proteins without CTP. The companys products under development include human growth hormone, which is used for the long-term treatment of children and adults with growth failure due to inadequate secretion of endogenous growth hormone; and factor IX that is offered to Hemophilia B patients to control blood clotting or coagulation. Its products under development also comprise anti-obesity peptide oxyntomodulin, factor VIIa, interferon ß and erythropoietin, and atherosclerosis and rheumatoid arthritis long-acting therapies. The company was formerly known as Modigene Inc. and changed its name to PROLOR Biotech, Inc. in June 2009. PROLOR Biotech, Inc. is based in Nes-Ziona, Israel. Key Statistics
| |
| | Pay | Exercised | Dr. Abraham Havron Ph.D.,
65
Chief Exec. Officer and Director | 345.00K | 0.00 | Mr. Shai Novik M.B.A.,
47
Pres, Director and Member of Governance Committee | 390.00K | 0.00 | Mr. Steven Schaeffer ,
63
Chief Financial Officer and Principal Accounting Officer | 48.00K | 0.00 | Dr. Eyal Fima M.B.A., Ph.D.,
48
Chief Operating Officer of Prolor Biotech Ltd | 205.00K | 0.00 | Dr. Fuad Fares D.Sc. ,
58
Director and Chief Scientific Officer of Prolor Biotech Ltd | 0.00 | 0.00 |
|
| | Amounts are as of Dec 30, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|
0.08(1.25%) May 24, 4:02PM EDT